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ABSTRACT
Motivation: A number of penalization and shrinkage approaches
have been proposed for the analysis of microarray gene expression
data. Similar techniques are now routinely applied to RNA sequence
transcriptional count data, although the value of such shrinkage
has not been conclusively established. If penalization is desired, the
explicit modeling of mean–variance relationships provides a flexible
testing regimen that ‘borrows’ information across genes, while easily
incorporating design effects and additional covariates.
Results: We describe BBSeq, which incorporates two approaches:
(i) a simple beta-binomial generalized linear model, which has not
been extensively tested for RNA-Seq data and (ii) an extension
of an expression mean–variance modeling approach to RNA-Seq
data, involving modeling of the overdispersion as a function of the
mean. Our approaches are flexible, allowing for general handling of
discrete experimental factors and continuous covariates. We report
comparisons with other alternate methods to handle RNA-Seq data.
Although penalized methods have advantages for very small sample
sizes, the beta-binomial generalized linear model, combined with
simple outlier detection and testing approaches, appears to have
favorable characteristics in power and flexibility.
Availability: An R package containing examples and sample
datasets is available at http://www.bios.unc.edu/research/genomic_
software/BBSeq
Contact: yzhou@bios.unc.edu; fwright@bios.unc.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
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1 INTRODUCTION
Sequencing of RNA-based libraries (‘RNA-Seq’) can provide
digital gene expression measurement, and is an attractive approach,
potentially replacing microarrays for analyzing the transcriptome in
an unbiased and comprehensive manner. For genes with very low
or very high levels, microarrays often lack sensitivity, or can result
in saturated signal. In contrast, RNA-Seq has been shown to have
high accuracy across many orders of expression magnitude (Marioni
et al., 2008), with clear advantages over microarray hybridization.
At a basic level, simple counts of RNA sequences can be used for
digital gene expression measurement, and are the subject of this
article. Additional information derived from the sequences, such as
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de novo exon discovery, are beyond our scope, although many of the
considerations here may be applied to the deeper study of sequence
content.
RNA-Seq technology is currently more expensive than
comparable array technologies, and thus the sample sizes are
typically small. In addition, even as the cost of RNA-Seq
profiling drops, the precision of the technology will enable
sensitive investigation of small samples (for example, pairwise
comparisons among many experimental conditions examined).
Eventually, however, we expect that sequence-based transcriptional
profiling will become the standard, with large datasets becoming
affordable. Thus, there is a pressing need for sensitive statistical
approaches that can accommodate large variation in the available
sample sizes.
RNA-Seq count data consists of the number of instances that each
transcript has been sequenced, arising from random sampling events
for a large number of sequences (the library size). The simplest
data model may be multinomial, with probability proportional
to the true expression level. These probabilities are small and
counts are accumulated over many reads, so Poisson approximations
are commonly used. However, it has been repeatedly shown that
RNA-Seq data are overdispersed (Robinson et al., 2010)—i.e. the
variance of sequence counts tends to be greater than would be
expected for multinomial or Poisson data. Thus, any careful analysis
of the data, and in particular any differential expression analysis,
must account for this overdispersion. Additional factors, such as the
length of the transcript and potential sequencing bias, are important
in performing inference on absolute expression levels, but here we
are concerned primarily with comparison of expression values across
different samples. Before proceeding to our testing framework, we
briefly review the available methods for performing differential
expression analysis for RNA-Seq data.
The package edgeR (Robinson et al., 2010) was initially designed
as a penalized approach to identify differences between two sample
groups. The current version has a variety of penalized overdispersion
approaches, including ‘common’ penalized dispersion, a ‘tagwise’
approach that shrinks individual genes/tags and the tagwise
procedure with a trend as a function of expression level. A negative
binomial model is used, which essentially corresponds to an
overdispersed Poisson model. The approach uses empirical Bayes
methods to moderate the degree of overdispersion, with the aim
of reducing error in a similar manner as penalized methods
in microarray analysis (Smyth, 2004). The baySeq approach
(Hardcastle and Kelly, 2010) is more explicitly Bayesian, also
assuming negative binomially distributed count data, and can use
the data to elicit a prior for the overdispersion parameters. BaySeq
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provides log posterior probability ratio for differential expression,
rather than P-values, limiting its utility somewhat for standard
multiple-testing approaches. The specification of multiple group
comparisons is somewhat complicated, as all types of alternatives (in
which some group subsets may be equivalently expressed) must be
considered. The package DESeq (Anders and Huber, 2010) employs
mean–variance estimation to produce moderated test statistics,
which is similar to a model that we describe below. DEGseq does not
accommodate overdispersion (Wang et al., 2010), and is not used
here for our comparisons.
1.1 Are new methods necessary?
For RNA-Seq data, it is important to consider whether purpose-
built procedures are necessary. Count data with overdispersion
can be modeled using standard generalized linear models (GLMs)
implemented in packages such as dispmod in R. The competing
methods described here produce shrunken estimates of differential
expression, which have been shown to be useful for microarray
analysis. However, for RNA-Seq, we are not aware that the need
for shrinkage or penalization has been carefully examined. An
additional danger is posed by sample outliers, which are more likely
to be encountered in large datasets, and for which the behavior
of the existing approaches is unknown. Similarly, the presence of
zero counts (e.g. all zeros in one of the compared experimental
conditions) can produce missing values or spurious tests. The vast
majority of publications have used purely simulated data, or small
example datasets for which comparative conclusions are difficult.
An exception is the Myrna package of Langmead et al. (2010),
who apply it to real HapMap YRI data and can analyze multiple
groups, but for which the count-based analysis is standard Poisson.
Analysis of future, more complex datasets will require more flexible
approaches.
In this article, we describe BBSeq, a comprehensive approach to
the analysis of RNA-Seq transcriptional count data. BBSeq assumes
a beta-binomial model for the count data, corresponding to the view
that the observation of a sequence for a particular transcript is a
Bernoulli random variable with an intrinsic probability for each
sample. These probabilities are allowed to vary according to a
beta distribution, thus allowing for overdispersion, with a mean
that depends on the design variables/covariates. As the library size
is large, the beta-binomial behaves similarly to an overdispersed
Poisson. We thus expect that the beta-binomial provides similar fits
as a negative binomial, which in the limit corresponds to a gamma-
Poisson mixture (Lawless, 1987). The beta-binomial model directly
describes unexplained variation in the sequence-read probabilities,
simplifying choices of starting values in model fitting, and in this
sense may provide a more direct interpretation of overdispersion
in the data. However, intuitive descriptions of overdispersion for
negative binomial data may be expressed in terms of coefficients
of variation. We use a logistic regression framework to describe
the dependence of expression on the experimental factors and
covariates, using generic design matrices for flexibility. In this
manner, any experimental factors or other covariates, such as age
or sex, can be considered. Overdispersion is handled as either
(i) a free parameter to be fit separately for each transcript or
(ii) a term that arises from a mean overdispersion model fit to the
data, with natural shrinkage properties and allowing information
to be shared across genes. BBSeq is intended as easy-to-use
software for handling RNA-Seq data, and our power/FDR results
indicate that straightforward beta-binomial modeling has favorable
characteristics. In contrast to the competing penalization approaches,
we find only modest advantages for penalization, which is mainly
useful for very small sample sizes.
2 METHODS
2.1 Mean–overdispersion modeling
The 60 HapMap CEU RNA-Seq samples from Montgomery et al. (2010)
(∼20 000 genes, described in detail below) are used to illustrate the
overdispersion typical of such datasets. Figure 1 shows the sample variance
versus the sample mean on the log–log scale for the read counts across the
samples. The relationship between the mean and variance is very strong,
and the overdispersion increases with mean expression, as evidenced by the
increasing gap between the data points and the unit line which corresponds
to a Poisson assumption. The pattern remains essentially unchanged if the
counts are standardized by the library size per sample (data not shown).
A similar plot using a random subset of five samples shows the same
pattern (Supplementary Fig. S1). The data illustrate that overdispersion is an
important feature of the data, and can either be fit as a separate parameter or in
a model for the dependence of the overdispersion on the average expression.
Discussions of RNA-Seq data often focus on the ‘length bias’, the
phenomenon that longer transcripts are more likely to contain mapped
reads. For example, Oshlack and Wakefield (2009) point out differing
mean–variance relationships for shorter versus longer genes. Supplementary
Figure S2 illustrates that, at least for datasets analyzed here, the mean is a
stronger determinant of the variance (and overdispersion) than the length
(also see Methods and Results in Supplementary Material). In addition, we
are mainly interested in comparing expression levels within genes, across
experimental conditions, and so the length bias is essentially a constant
feature for these comparisons.
2.2 Data format and definitions
The data consist of an m × n matrixY, with m genes and n samples. Each entry
yij represents the transcriptional count for the i-th gene in the j-th sample.
We will use θij to denote the probability that a single read in sample j maps
to gene i, and θi. as the n-vector of these probabilities. The beta-binomial
models θ as a random variable, which produces the overdispersion. Reads
within the same sample are assumed independent. X will denote an n×p
design matrix, consisting of indicator variables for experimental conditions







for the p×1 matrix of regression coefficients Bi =[β0,i,..,βp−1,i]T .
θij follows a Beta distribution, parameterized so that its variance is
φiE(θij)(1−E(θij)). Values φ>0 correspond to overdispersion compared
with the binomial, after considering design effects. We will use sj =∑i yij to






B(yij +α1ij,sj −yij +α2ij)
B(α1ij,α2ij)
(2)
where B() is the Beta function, α1ij =E(θij)(1−φi)/φi, and α2ij = (1−φi)
(1−E(θij))/φi.
Parameter estimation is performed by maximum likelihood, using either
of two approaches:
(i) the free model, in which φi is estimated as a ‘free’parameter separately
for each gene; and
(ii) the constrained model, in which φi is estimated using an assumed
mean–overdispersion relationship. For the constrained model, it might
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Fig. 1. The mean–variance relationship in the CEU data suggests a mean–
overdispersion relationship. A third-degree polynomial fit is also shown.
be reasonable for the overdispersion to also depend on the sample j,
but for simplicity and comparability with the free model it is simpler
to assume a single φ for each gene i. Each φi ∈[0,1], and so it is
convenient to work with a logistic transformed parameter, and we





where the mean is over the n-vector XBi. Note that the logit
specification does not allow for underdispersion, which would be
biologically implausible. In practice, a low degree polynomial, with
K ≤3, appears to provide an adequate fit, and we use simple plug-
in estimates B̂i and φ̂i from the free model to obtain least squares
estimates of the γ values. The γ values are assumed to be the
same across the genes. This approach is similar to and generalizes
a mean–variance modeling approach for expression microarrays
(Hu and Wright, 2007),which had previously been performed only
for two-sample experiments. The intent of the modeling is to increase
power to detect differential expression for small sample sizes. Note
that the estimation of the mean–overdispersion relationship does not
reduce the degrees of freedom for individual genes, as all genes are
used to estimate the few γ parameters.
Supplementary Figure S3a shows the ψ̂ values obtained from the free
model for 6 versus 6 samples from the CEU dataset, with equal number of
males and females in each group, plotted against mean(XB̂). The relationship
is reasonably polynomial, inspiring the constrained model, with much of the
variation in ψ̂ explained (multiple R2 = 0.60 for a cubic fit). Moreover, the
variation in the ψ̂ residuals can mostly be attributed to sampling variation
consistent with the ψ̂ standard errors (Supplementary Fig. S3b).
Optimization for both models is performed using the R optim function,
with starting values for Bi obtained from linear regression and for ψ̂ from
marginal evidence of overdispersion (without considering design effects).
Finally, we note that real data can produce outlying estimates for a
small percentage of genes, especially for the constrained model and large
sample sizes. Thus, we have devised very simple outlier detection/correction
approaches to avoid spurious results (Methods and Results in Supplementary
Material).
2.3 Testing and design matrices
The free and constrained models both provide considerable flexibility, as
the design matrix X is arbitrary and can be specified by the user. The
statistical significance of any covariate can then be determined from the
corresponding Wald statistic (the estimate of differential expression divided
by its standard error). The vast majority of published RNA-Seq studies
involve simple two-sample comparisons, so the primary testing is on β1i
in each Bi, corresponding to the indicator column in X representing group
assignment. Empirical investigation in small samples indicates that the Wald
statistic β̂1/SE(β̂1) is distributed approximately tn−p for the free model under
the null hypothesis (and standard normal for constrained), with adjustments
for zero counts in the data (Methods and Results in Supplementary Material),
and we employ this approximation for two-sample testing.
Many future studies are likely to focus on a few (perhaps multilevel)
factors, as is performed in ANOVA analysis. Thus, BBSeq has been
designed with a simple function to generate design matrices corresponding to
multilevel factors. Moreover, BBSeq performs likelihood ratio comparisons
for the overall statistical significance of each included factor. A more
detailed description is provided in Methods and Results of Supplementary
Material for the CEU HapMap samples, along with a real example for which
etoposide IC50 cytotoxicity response scores (Huang et al., 2007) are used as
a continuous predictor, along with sex and the sex × IC50 interaction.
In summary, BBSeq is designed to make it easy to perform testing for a
variety of experimental designs, with modifications for small sample sizes
to take advantage of the mean–overdispersion relationship.
2.4 HapMap RNA-Seq data sources
The CEU HapMap lymphoblastoid RNA-seq dataset of Montgomery
et al. (2010) was obtained from their website (60 samples, http://
jungle.unige.ch/rnaseq_CEU60/) as mapped tags (these and all
other data downloaded in March 2010). RefSeq annotation for 21 498
genes (corresponding to 32 644 transcriptional isoforms) from the hg18
genome build was downloaded from the UCSC Genome Browser (http:
//genome.ucsc.edu/), with gene/exon boundaries used for a transcript
database. Mismatches of up to two bases were allowed. Counts were
obtained by summing RNA-Seq reads mapping to the exons of each RefSeq
entry, and RefSeq IDs further annotated to the official gene symbol. An
average of 9.8 million reads per sample were mapped. Mapping of reads
to multiple transcript isoforms were kept in the dataset for completeness.
Differential expression analyses using only the most-common isoforms for
each gene versus retaining all isoforms as if they were separate genes
resulted in nearly identical inference. Mapped reads from the Argonne
HapMap YRI dataset (69 unique samples), Pickrell et al., 2010 were
downloaded from http://eqtl.uchicago.edu/RNA_Seq_data/
mapped_reads/, extracted and applied to hg18 using the same procedures
as performed for the CEU data (an average of 4.3 million mapped per
sample). The total number of genes containing mapped reads in the CEU
dataset was 20 904 (32 027 with redundant isoforms included), and in the
YRI dataset was 20 488 (31 508).
2.5 Simulated data and subsampling from real datasets
For simulated datasets, as well as analysis of the HapMap data, the
two BBSeq models were compared with other approaches, including the
three edgeR models, DESeq, baySeq and a quasi-likelihood overdispersed
binomial GLM (detailed descriptions of Methods in Supplementary
Material).
Dataset 1: the first dataset consists of 100 independent simulations of
10 000 genes with 5 versus 5 samples for two-sample comparisons, reported
in Hardcastle and Kelly (2010) (under ‘Random dispersion simulations’).
A known 10% of the genes were differentially expressed with a ratio of
average count levels of (
√
8) between two experimental groups. The data
were obtained from the authors, who used edgeR parameter estimates from
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a SAGE dataset (Zhang et al., 1997). However, it is not clear whether the
simulation setup mimics current RNA-Seq data.
Dataset 2: the second dataset consisted of our own simulations of two-
sample comparisons of groups 1 and 2 (n1 =5 versus n2 =5 or n1 =2 versus
n2 =2 ), with average expression levels matched to that of a real RNA-Seq
dataset. For a two-sample experiment, the coefficient matrix is B=[β0,β1]T




to control the degree of differential expression, which is interpretable as
the odds ratio for the expected read probabilities in group 2 versus group
1. Values r>1, r<1 and r =1 correspond to group 2 having greater,
lower and equal average expression, respectively, as group 1. To obtain
empirically driven parameter values, we first drew random subsamples of
the CEU data (Montgomery, 2010), and for each subsample ran the free
and constrained models to obtain β0, and γ estimates for each gene. Then
for each value r, 20 simulations were performed following Equation (3),
treating the estimated values as true parameters, with 10% of the genes
chosen to be differentially expressed (i.e. with r at the alternate value),
which together with β0 determined the corresponding β1. Then the data were
simulated according to the corresponding beta-binomial distribution, with
library sizes (total number of reads) obtained from the actual samples. Any
simulated genes consisting entirely of zero counts across the samples were
removed. For the receiver operator characteristic (ROC) curve comparisons,
we attempted to make the results as realistic as possible by using, for null
genes and each simulation, the actual read counts drawn from a random set
of n1 versus n2 samples drawn from the full CEU dataset. Although both
Datasets 1 and 2 consist of simulations, with Dataset 2 we attempted to
closely follow features of a modern RNA-Seq dataset, to be as realistic as
possible.
Dataset 3: it is difficult for simulations to capture the complexities of real
data, but it is also difficult to obtain RNA-Seq datasets for which the ‘truth’
of differential expression is known. Moreover, results from any single small
dataset can be highly variable, and possibly not reflect the overall behavior of
a procedure. We reasoned that comparisons of differentially expressed genes
between males and females in the HapMap RNA-Seq datasets would be an
ideal testing ground for the ability to detect differential expression, and we
used subsamples of the CEU and YRI HapMap data to form our third dataset.
Genes on the sex chromosomes would be expected to predominate among
those most differentially expressed. Despite chromosomal inactivation, a
sizeable number of X-chromosome genes are differentially expressed, with
modern estimates of this proportion ranging from ∼15% (Carrel and Willard,
2005) to 5% (Johnston et al., 2008). Y chromosome genes should be
expressed only in males, but the expression in transformed lymphocytes
for many genes may be low. Nonetheless, using the genes on the autosomes
as a control, the ability to efficiently detect differential expression on the
sex chromosomes can be used to compare procedures, with the degree of
differential expression varying widely across this set.
3 SIMULATIONS AND EXAMPLES
3.1 Comparisons with other approaches
3.1.1 Comparisons using Dataset 1 The original authors
(Hardcastle and Kelly, 2010) used ROC curves to compare baySeq to
a number of other methods, including edgeR. Focusing on the most
significant genes and expressed as a false discovery rate produces
the result in Supplementary Figure S5, which is directly comparable
to the lower right panel of Figure 2 in Hardcastle and Kelly (2010).
BaySeq has the best performance, while our two approaches perform
similarly to edgeR and DESeq for the most significant genes, but
perform more poorly for larger numbers of rejected genes. A careful
comparison shows that the free model is similar to the unpenalized
Fig. 2. Power comparisons for one scenario, Dataset 2.
‘log-linear’ model in the original baySeq figure, as expected, as is
the overdispersed GLM.
The results are perhaps to be expected, as the data follow
the idealized simulation conditions for baySeq. Supplementary
Figure S5 shows the relationship between log(variance) and
log(mean) for the first group in the first simulation. Although
there is an apparent mean–overdispersion relationship, note that the
dispersion in sample variance is more extreme, especially for genes
with low expression than encountered in the CEU data (Fig. 1 and
Supplementary Fig. S1). Moreover, the average expression level in
the real RNA-Seq datasets tends to be higher than for Dataset 1. This
difference is strikingly illustrated in the number of zero counts. For
either the CEU or YRI datasets, ∼60% of the genes in a subsample
of size 10 will show no zero counts across the samples, while for
Dataset 1 the value is 17%. It is unclear how these differences affect
the performance of these methods with current RNA-Seq data.
3.1.2 Comparisons using Dataset 2 As described earlier, Dataset
2 consists of simulations with n1 =n2 =2 and n1 =n2 =5, under
the model using intercept β0 and mean–overdispersion relationships
obtained from the CEU data, with parameter r controlling the degree
of true differential expression. In each simulation, a random 10% of
the genes were used as ‘alternative’. We were interested in power
to declare differential expression at α=0.05 and the more stringent
α=0.001. Such a comparison requires interpretable P-values, and
so we do not show results for baySeq, which provides only posterior
probabilities for differential expression. The remaining approaches
exhibited reasonable control of type I error, but to make precise
power comparisons we also determined the empirical threshold for
each approach such that Pr=1(p<pthreshold)=α. An illustrative
power curve for n1 =n2 =2 and α=0.05 is shown in Figure 2. The
additional scenarios are shown in Supplementary Figure S6.
For these simulations, the constrained model performs best, as
might be expected, as the approach is able to accurately estimate
overdispersion using the model. The relative improvement in power
for the constrained model over the other models is greatest for
n1 =n2 =2 and α=0.001, and for modest effect sizes r. For
n1 =n2 =5, the relative improvement of the constrained model over
other penalized approaches is reduced.
For these simulations, the empirical type I error for the nominal
P-values is shown in Supplementary Table S1. The BBSeq models
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show near-nominal type I error, while the other methods do not
generally perform as well. Focusing on n1 =n2 =5 and a moderate
effect size r =2.0 and using the resampled data counts to create
‘null’genes as described above, we show ROC curves for the various
methods in Figure 3. Examination of ROC curves reveal differing
behavior for genes with low expression versus high expression
(using the median β0 estimate as a splitting criterion). Here, the
free model outperforms the other models, except for high expression
genes, where it is similar to baySeq and to the overdispersed GLM.
However, using all genes, the free model appears to be best. Note
that these results differ somewhat from the ‘pure’ simulations for
the power curves, because the sampling of null genes by random
draws from the CEU induces correlations and dispersion behavior
that may not be reflect in pure null simulation.
Based on these simulations and potential sensitivity to the vagaries
of real data, we propose that the constrained model has value mainly
for very small sample sizes (such as n1 =n2 =2), with the theoretical
advantages for larger sample sizes outweighed by potential model
deviations. Thus, we recommend the constrained model only for
very small sample sizes.
After consideration of the simulations, we were motivated to
compare the free model to competing models for moderate sample
sizes and real data. These comparisons are performed in Dataset 3
below.
3.1.3 Comparisons using Dataset 3 Using the sex information
for the CEU HapMap and YRI samples, we applied the free model
and the competing approaches to 10 random subsamples of n1 =6
males versus n2 =6 females for CEU and YRI separately. For the
edgeR approach, we used only the trend penalization procedure, as
this had performed generally the best in the power comparisons. For
each subsample, we counted the number of sex chromosome genes
among the top detected/rejected genes. The average across the 10
subsamples is shown in Figure 4. Here, the free model is best for
the CEU data, and is similar to edgeR, DESeq and the GLM for the
YRI data. For YRI, the baySeq approach is the most sensitive in
detection.
These comparisons are among the most extensive such
examinations performed with real data and for which we are able
to explore the ‘truth’ of differential expression in the dataset.
We emphasize that true differential expression between males and
females may occur for some genes on the autosomes. The rationale
of our analysis, following current understanding of sex chromosome
expression, is merely that genes on the sex chromosomes should be
over-represented if a detection procedure is sensitive.
As described in Section 2, for completeness of mapped reads,
our analyses were performed using multiple common transcript
isoforms (e.g. splicing variants) as if they were separate genes.
Many reads map to several isoforms of a gene, technically violating
independence assumptions for read counts. RNA-Seq analysis
packages typically provide little guidance on this issue. However,
the library sizes are typically so large that the inference for any
one isoform is essentially the same whether or not the analysis
is restricted to unique genes, as illustrated for a 12-sample CEU
analysis, shown in Supplementary Figure S7.
3.1.4 Sex-specific expression and outlier sensitivity We also used
the five methods to perform differential expression analysis for




Fig. 3. Portions of ROC curves for Dataset 2. (A) The curve for low-
expression genes with the x-axis ranging 0–0.01 (see text); (B) a similar set
of curves for high-expression genes; (c) all genes, but with a more stringent
1− specificity.
Knowledge of X-inactivation and dosage compensation remains
surprisingly incomplete, and microarray analysis of HapMap cell
lines (including CEU and YRI) by Johnston et al. (2008) has
provided much of our recent understanding of genes that are
inactivated (or effectively so) in females. Interestingly, among the
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A B
Fig. 4. Number of detected genes on the sex chromosomes versus number
of genes detected, using subsamples from Dataset 3 with n1 =6 males versus
n2 =6 females. (A) The CEU dataset; (B) the YRI data.
top 10 genes identified by the free model (Table 1), 9 are on the
X chromosome and all were described by Johnston et al. (2008) or
Carrel and Willard (2005) as escaping inactivation. It is reassuring
that the known X-inactivator XIST (Herzing et al., 1997) is the most
differentially expressed gene [although technically with the cDNA-
based technology, it cannot be distinguished from its antisense
counterpart TSIX (Lee et al., 1999)]. Analysis of the entire gene
list (data not shown) shows many Y chromosome genes ranking
highly, but typically with lower read counts and correspondingly
lower significance. The GLM approach similarly identifies 9 genes
on X among the top 10, although XIST is ranked much lower
(162nd). Unlike the free model, both edgeR with Trend and DESeq
identify only XIST among the top 10 genes. For these methods, the
XIST result is strikingly significant, which we attribute to differing
variances within each of males and females (data not shown), to
which these methods may be more sensitive. Bayseq identifies three
genes from the X chromosome among the top 10. We were interested
in the reasons for such strikingly different gene lists. For each
approach, we examined the most significant autosomal genes, and
some potentially spurious results emerged. Separate male/female
histograms of normalized read counts are plotted in Supplementary
Figure S8. The top autosomal gene from the free and GLM models,
FAHD2A (free model P = 5.86E-11, GLM P = 1.78E-07, has not
been widely described, and a literature search did not reveal
compelling evidence for sex-specific expression. Nonetheless, the
histogram shows a clear trend of higher expression in males. SULF1
does not appear differentially expressed (Supplementary Figure S8),
but has P = 7.82E-42 according to edgeR Trend, and P = 8.14E-
47 according to DESeq This result is largely driven by a single
outlying high value in females. BaySeq identifies ACTG1 as the most
differentially expressed of all genes, although the count distributions
overlap almost entirely, with the two highest values occurring in
females. We speculate that the high expression of the gene (fourth
highest among all genes) may make it vulnerable to spurious baySeq
findings, but further investigation is warranted. Beyond the potential
sensitivity to outliers, most of the methods are in broad agreement—
e.g. the top-ranked genes by the free model are also significant by
the other methods, but appear further down on their respective lists.
The entire list of genes and P-values for all methods are provided
on the software website.
4 CONCLUSION AND DISCUSSION
We have described a procedure to implement beta-binomial
modeling of RNA-Seq tag counts. For the free-φ model, our
procedure is somewhat similar to other overdispersed generalized
linear models. However, in our simulations and in the HapMap
data, the direct parametric modeling of the overdispersion parameter
appeared to be advantageous. Moreover, our BBSeq software
simplifies the analysis for researchers less familiar with modeling
and construction of design matrices, and issues such as outlier
detection are handled automatically. The constrained-φ approach,
while still very simple, has potential advantages in the analysis of
very small datasets, which remain very common. We emphasize
that both procedures offer much more flexible handling of
design variables and other covariates than competing purpose-built
procedures.
A surprising result from our investigation is that it is unclear for
modest size samples (say 5 or more per sample group) that the
careful attention to penalization procedures, which are implicit in
both the competing procedures and in our constrained approach,
are truly necessary for effective inference. A better understanding
of the true nature of differential expression may be necessary in
order to fully understand these issues. Much of the motivation
behind penalized approaches lies in a notion that genes with low
expression have an unfavorable ratio of signal to noise. As the
accuracy of expression profiling further improves, this notion may
be replaced by a deeper understanding of the degree of differential
expression need to produce biologically important changes, which
may depend on baseline expression level as well as other contextual
information. Our analysis of male/female differential expression in
the entire CEU dataset was intended only as a simple illustration, but
highlights a possible sensitivity to outliers of shrinkage/penalization
methods, and deserves further investigation.
Several investigators have pointed out that a relatively small
number of genes can be responsible for large variations in total
read counts (Robinson and Oshlack, 2010; Bullard et al., 2008), and
thus it is conceivable that a gene at constant mRNA concentration
might appear to vary. This phenomenon would be expected to be
strongest in differential expression experiments involving widely
divergent samples (e.g. liver and kidney samples, as in Robinson and
Oshlack, 2010). For datasets of the same tissue type, as described
here, we expect that total read counts will remain a sound basis for
normalization. However, these considerations suggest that further
extensions of BBSeq modeling might consider alternate terms which
reflect the sources of such read count variation.
The procedures described here reflect only global gene expression
changes, ignoring the rich mRNA sequence information. Extensions
to BBSeq could potentially be used to summarize evidence of allele-
specific expression and differential expression, and to investigate
differential expression of various isoforms (Blekhman et al., 2010).
Sequence reads that are otherwise uninformative about allele
specificity or varying isoforms still provide evidence of overall
expression level, which in turn may indirectly inform a deeper
understanding of expression changes.
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Table 1. Top differentially expressed genes for 27 males versus 33 females, CEU dataset
Free edgeRtrend baySeq DESeq GLM
chrX XIST 1.73E-11 chrX XIST 1.03E-213 chr17 ACTG1 94.4 chrX XIST 8.82E-227 chrX EIF1AX 1.34E-14
chrX PNPLA4 5.86E-11 chr7 ABP1 2.80E-42 chrX XIST 44.58 chr7 ABP1 3.86E-53 chrX PNPLA4 5.27E-14
chrX EIF1AX 2.36E-10 chr8 SULF1 7.82E-42 chr11 RPS3 37.49 chr2 RAPH1 3.90E-52 chrX HDHD1A 1.30E-11
chrX NLGN4X 2.09E-08 chr2 RAPH1 1.16E-40 chr22 RPL3 28.82 chr22 MIR650 9.95E-49 chrX RPS4X 4.27E-11
chrX RPS4X 4.22E-08 chr22 MIR650 1.72E-37 chr12 RPLP0 26 chr8 SULF1 8.14E-47 chrX KDM6A 6.57E-09
chrX HDHD1A 5.06E-08 chr20 EEF1A2 9.58E-27 chr15 PKM2 24.7 chr11 NEAT1 6.77E-31 chrX KDM5C 3.03E-08
chrX PRKX 5.62E-07 chr12 HMGA2 3.48E-22 chrX NLGN4X 21.27 chr20 EEF1A2 2.30E-19 chrX NLGN4X 6.60E-08
chrX KDM6A 6.38E-07 chr2 SCN3A 1.54E-19 chr22 MYH9 20.13 chr12 HMGA2 2.87E-19 chrX PRKX 6.69E-08
chr2 FAHD2A 1.19E-06 chr1 S100A8 6.42E-18 chr13 LCP1 19.71 chr14 IFI27 2.26E-18 chr2 FAHD2A 1.78E-07
chrX CXorf15 1.43E-06 chr18 DSG1 7.40E-18 chrX EIF1AX 18.35 chr15 GOLGA8B 1.82E-17 chrX CXorf15 2.62E-07
BaySeq results are shown as log posterior odds for differential expression.
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Note Added in Proof : The advance access version of this manuscript
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the error. In addition, analysis of the full CEU dataset by an updated
version of baySeq (version 1.6) is reported to identify fewer outliers
(Dr. Thomas Hardcastle, personal communication).
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